NMDS Group logo

NMDS Group

Exploring the role of epigenetic alterations in myeloid malignancies with focus on drug response

Hani Abdulkadir Ali

Date: 2018-12-14

Time: 9:00

Venue: GENE, NEO (Room 5108), floor 5, KI Campus Flemingsberg
Blickagången 16, 141 52 Huddinge

Hani Abdulkadir Ali, Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine - HERM 

Main supervisor: Associate professor Johanna Ungerstedt, Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine - HERM 

Co-supervisor: Professor Eva Hellström-Lindberg, Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine - HERM 

Co-supervisor: Associate professor Andreas Lennartsson, Dep. of Biosciences and och nutrition (BioNut)

Co-supervisor: Dr Mohsen Karimi Arzenani, Dep. of Medicine, Solna, Center for Molecular Medicine CMM

Opponent: Professor Jörg Cammenga, Linköping University, Dep. of Clinical and Experimental Medicine (IKE)

The Danish Cancer Society has granted 20 mio DKK to a new Danish research center headed by professor Kirsten Grønbæk. The center will at first focus on precision medicine in AML and MDS. 

https://www.cancer.dk/nyheder/20-mio-kr-fra-knaek-cancer-gaar-til-forskningscenter-for-ny-medicin-til-blodkraeft/